Liaoyuan City Baikang Pharmaceutical Co., Ltd.

Primary objective: To study the relative bioavailability of cloperidine hydrochloride tablets (test preparation, 10 mg/tablet) produced by Liaoyuan Baikang Pharmaceutical Co., Ltd. and cloperidine hydrochloride tablets (reference preparation, 10 mg/tablet) produced by Nipro ES Pharmaceutical Co., Ltd. in healthy subjects in the fasting/postprandial state, and to evaluate the bioequivalence between the test preparation and the reference preparation. Secondary objective: To observe the safety and tolerability of the test preparation and the reference preparation in healthy Chinese subjects through changes in adverse event incidence, laboratory test results, vital signs and physical examinations.

Primary objective: To study the relative bioavailability of cloperidine hydrochloride tablets (test preparation, 10 mg/tablet) produced by Liaoyuan Baikang Pharmaceutical Co., Ltd. and cloperidine hydrochloride tablets (reference preparation, 10 mg/tablet) produced by Nipro ES Pharmaceutical Co., Ltd. in healthy subjects in the fasting/postprandial state, and to evaluate the bioequivalence between the test preparation and the reference preparation. Secondary objective: To observe the safety and tolerability of the test preparation and the reference preparation in healthy Chinese subjects through changes in adverse event incidence, laboratory test results, vital signs and physical examinations.